COVID vaccines offered varying degrees of protection in the six months after patients receive them, with levels climbing and plunging in two cases and climbing and climbing in another, according to new UC San Francisco research ...
May 9, 2023
0
51
The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.
May 3, 2023
0
10
Travelers to the United States will now only need a single bivalent COVID vaccine from either Pfizer or Moderna to enter the country, the U.S. Centers for Disease Control and Prevention announced Thursday.
Apr 28, 2023
0
2
An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show.
Apr 6, 2023
0
5
US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.
Mar 13, 2023
0
2
The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.
Mar 10, 2023
0
8
In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up.
Mar 1, 2023
0
8
A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system.
Feb 22, 2023
1
215
American adults who have no health insurance or those who are underinsured will still be able to get free COVID-19 vaccines from Moderna, even after government-purchased supplies run out, the company announced Monday.
Feb 17, 2023
0
16
After two straight years of surging sales due to COVID-19 products, Pfizer projected a steep decline in 2023 revenues as demand for vaccines and therapeutics ebbs.
Jan 31, 2023
0
5
